PSYCHODERMATOLOGY - PRACTICAL GUIDELINES ON PHARMACOTHERAPY

被引:69
作者
KOO, JYM
PHAM, CT
机构
关键词
D O I
10.1001/archderm.128.3.381
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. -The importance of emotional factors in dermatologic disorders has been recognized for several decades. However, there have been few reports on the management of psychodermatologic disorders. Meanwhile, there has been tremendous progress in the pharmacologic treatment of these conditions. This article describes major categories of psychodermatologic disorders and provides practical management guidelines, emphasizing the use of selected psychopharmacologic agents. Observations. -Psychodermatologic conditions can be divided into three broad subgroups: psychophysiologic disorders in which the severity of primary cutaneous disease is influenced by the patients' emotions; primary psychiatric disorders in which the skin conditions are self-induced and reflect underlying psychopathologic conditions; and secondary psychiatric disorders in which the patients experience psychologic problems as a result of disfigurement associated with the skin conditions. There are many ways to manage these psychodermatologic conditions, including psychotherapy, behavioral therapy, and psychopharmacotherapy. To determine which pharmacologic agent is most appropriate, the nature of the underlying psychopathologic condition such as anxiety, depression, psychosis, and obsession/compulsion should be identified. Furthermore, there are nonpsychiatric disorders encountered by dermatologists in which psychopharmacologic agents may be more efficacious than conventional therapeutics. Conclusion. -We conclude that psychopharmacologic agents provide a useful option to the management of psychodermatologic disorders.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 95 条
[1]  
AGRAS WS, 1990, J CLIN PSYCHIAT, V51, P52
[2]  
[Anonymous], 1986, MED LETT DRUGS THER, V28, P117
[3]   INTERACTION OF ANTIDEPRESSANTS AND NEUROLEPTICS WITH HISTAMINE STIMULATED PARIETAL-CELL ADENYLATE-CYCLASE AND H+ SECRETION [J].
BEIL, W ;
HANNEMANN, H ;
SEWING, KF .
PHARMACOLOGY, 1988, 36 (03) :198-203
[4]   INHIBITION OF HISTAMINE-INDUCED PRURITUS BY TOPICAL TRICYCLIC ANTI-DEPRESSANTS [J].
BERNSTEIN, JE ;
WHITNEY, DH ;
SOLTANI, K .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1981, 5 (05) :582-585
[5]   MONOSYMPTOMATIC HYPOCHONDRIACAL SYNDROMES IN DERMATOLOGY [J].
BISHOP, ER .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1983, 9 (01) :152-158
[6]  
BREITBART W, 1989, J PAIN SYM MANAG S3, V4, P2
[7]  
COHN JB, 1986, J CLIN PSYCHIAT, V47, P409
[8]  
COLE JO, 1990, J CLIN PSYCHIAT, V51, P21
[9]  
COLEMAN JH, 1975, DIS NERV SYST, V36, P591
[10]  
COTTERILL JA, 1990, SEMIN DERMATOL, V9, P216